Baudax Bio
As of the edition of 20 October 2026, Baudax Bio runs 2 drugs, 1 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
Baudax Bio was bankrupt in 2024.
- Baudax Bio: bankrupt in 2024
Drugs by status
| Status | Count |
|---|---|
| Marketed | 1 |
| Status not established | 1 |
| Total | 2 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Meloxicam | none listed | 1 |
A route B row is one company at one target.